{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:02:57Z","timestamp":1781877777638,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T00:00:00Z","timestamp":1289174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/bmt.2010.261","type":"journal-article","created":{"date-parts":[[2010,11,8]],"date-time":"2010-11-08T11:54:15Z","timestamp":1289217255000},"page":"1089-1098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT"],"prefix":"10.1038","volume":"46","author":[{"given":"L","family":"Kr\u00f3l","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Stuchl\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Hub\u00e1\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Keslov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sedl\u00e1\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Star\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Hru\u0161\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kalina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,8]]},"reference":[{"key":"BFbmt2010261_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0966-842X(03)00066-0","volume":"11","author":"M Scholz","year":"2003","unstructured":"Scholz M, Doerr HW, Cinatl J . Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence. Trends Microbiol 2003; 11: 171\u2013178.","journal-title":"Trends Microbiol"},{"key":"BFbmt2010261_CR2","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1182\/blood-2002-05-1387","volume":"100","author":"E Ozdemir","year":"2002","unstructured":"Ozdemir E, St John LS, Gillespie G, Rowland-Jones S, Champlin RE, Molldrem JJ et al. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood 2002; 100: 3690\u20133697.","journal-title":"Blood"},{"key":"BFbmt2010261_CR3","first-page":"71","volume":"84","author":"R Stocchi","year":"1999","unstructured":"Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF . Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica 1999; 84: 71\u201379.","journal-title":"Haematologica"},{"key":"BFbmt2010261_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clim.2009.02.002","volume":"131","author":"D Lilleri","year":"2009","unstructured":"Lilleri D, Zelini P, Fornara C, Comolli G, Revello MG, Gerna G . Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host. Clin Immunol 2009; 131: 395\u2013403.","journal-title":"Clin Immunol"},{"key":"BFbmt2010261_CR5","doi-asserted-by":"publisher","first-page":"5711","DOI":"10.1182\/blood-2008-10-143560","volume":"113","author":"M Boeckh","year":"2009","unstructured":"Boeckh M, Ljungman P . How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009; 113: 5711\u20135719.","journal-title":"Blood"},{"key":"BFbmt2010261_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jcv.2007.12.001","volume":"41","author":"F Baldanti","year":"2008","unstructured":"Baldanti F, Lilleri D, Gerna G . Monitoring human cytomegalovirus infection in transplant recipients. J Clin Virol 2008; 41: 237\u2013241.","journal-title":"J Clin Virol"},{"key":"BFbmt2010261_CR7","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1182\/blood-2002-11-3472","volume":"102","author":"M Hakki","year":"2003","unstructured":"Hakki M, Riddell SR, Storek J, Carter RA, Stevens-Ayers T, Sudour P et al. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood 2003; 102: 3060\u20133067.","journal-title":"Blood"},{"key":"BFbmt2010261_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00281-008-0132-5","volume":"30","author":"J Storek","year":"2008","unstructured":"Storek J, Geddes M, Khan F, Huard B, Helg C, Chalandon Y et al. Reconstitution of the immune system after hematopoietic stem cell transplantation in humans. Seminars in immunopathology 2008; 30: 425\u2013437.","journal-title":"Seminars in immunopathology"},{"key":"BFbmt2010261_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.bmt.1700612","volume":"19","author":"VA Nicholson","year":"1997","unstructured":"Nicholson VA, Whimbey E, Champlin R, Abi-Said D, Przepiorka D, Tarrand J et al. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis. Bone Marrow Transplant 1997; 19: 37\u201341.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010261_CR10","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","volume":"88","author":"M Boeckh","year":"1996","unstructured":"Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA . Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996; 88: 4063\u20134071.","journal-title":"Blood"},{"key":"BFbmt2010261_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1182\/blood-2002-03-0993","volume":"101","author":"M Boeckh","year":"2003","unstructured":"Boeckh M, Leisenring W, Riddell SR, Bowden RA, Huang M-L, Myerson D et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003; 101: 407\u2013414.","journal-title":"Blood"},{"key":"BFbmt2010261_CR12","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1182\/blood.V97.5.1232","volume":"97","author":"K Cwynarski","year":"2001","unstructured":"Cwynarski K, Ainsworth J, Cobbold M, Wagner S, Mahendra P, Apperley J et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 2001; 97: 1232\u20131240.","journal-title":"Blood"},{"key":"BFbmt2010261_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1086\/591185","volume":"198","author":"H Moins-Teisserenc","year":"2008","unstructured":"Moins-Teisserenc H, Busson M, Scieux C, Bajzik V, Cayuela JM, Clave E et al. Patterns of Cytomegalovirus Reactivation Are Associated with Distinct Evolutive Profiles of Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis 2008; 198: 818\u2013826.","journal-title":"J Infect Dis"},{"key":"BFbmt2010261_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/cyto.b.20420","volume":"74","author":"JW Gratama","year":"2008","unstructured":"Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG et al. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations. Cytometry Part B, Clinical cytometry 2008; 74: 211\u2013220.","journal-title":"Cytometry Part B, Clinical cytometry"},{"key":"BFbmt2010261_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1399-3062.2009.00446.x","volume":"11","author":"AJ Eid","year":"2009","unstructured":"Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR et al. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation. Transplant Infectious Disease 2009; 11: 519\u2013528.","journal-title":"Transplant Infectious Disease"},{"key":"BFbmt2010261_CR16","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1086\/648423","volume":"49","author":"A Barron Michelle","year":"2009","unstructured":"Barron Michelle A, Gao D, Springer Kathryn L, Patterson Julie A, Brunvand Mark W, Mcsweeney Peter A et al. Relationship of Reconstituted Adaptive and Innate Cytomegalovirus (CMV)\u2013Specific Immune Responses with CMV Viremia in Hematopoietic Stem Cell Transplant Recipients. Clin Infect Dis 2009; 49: 1777\u20131783.","journal-title":"Clin Infect Dis"},{"key":"BFbmt2010261_CR17","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1182\/blood-2007-05-092130","volume":"110","author":"KV Komanduri","year":"2007","unstructured":"Komanduri KV, St John LS, De Lima M, Mcmannis J, Rosinski S, Mcniece I et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 2007; 110: 4543\u20134551.","journal-title":"Blood"},{"key":"BFbmt2010261_CR18","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/bmt.2008.403","volume":"43","author":"B Pourgheysari","year":"2009","unstructured":"Pourgheysari B, Piper KP, McLarnon A, Arrazi J, Bruton R, Clark F et al. Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT. Bone Marrow Transplant 2009; 43: 853\u2013861.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010261_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/sj.bmt.1705932","volume":"41","author":"Y Morita-Hoshi","year":"2008","unstructured":"Morita-Hoshi Y, Heike Y, Kawakami M, Sugita T, Miura O, Kim S-W et al. Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 515\u2013521.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010261_CR20","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/nm1292","volume":"11","author":"M Frentsch","year":"2005","unstructured":"Frentsch M, Arbach O, Kirchhoff D, Moewes B, Worm M, Rothe M et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med 2005; 11: 1118\u20131124.","journal-title":"Nat Med"},{"key":"BFbmt2010261_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","volume":"281","author":"MR Betts","year":"2003","unstructured":"Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65\u201378.","journal-title":"J Immunol Methods"},{"key":"BFbmt2010261_CR22","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1084\/jem.20052246","volume":"203","author":"JP Casazza","year":"2006","unstructured":"Casazza JP, Betts MR, Price DA, Precopio ML, Ruff LE, Brenchley JM et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 2006; 203: 2865\u20132877.","journal-title":"J Exp Med"},{"key":"BFbmt2010261_CR23","doi-asserted-by":"publisher","first-page":"6167","DOI":"10.4049\/jimmunol.0902068","volume":"183","author":"TK Kim","year":"2009","unstructured":"Kim TK, St John LS, Wieder ED, Khalili J, Ma Q, Komanduri KV . Human late memory CD8+ T cells have a distinct cytokine signature characterized by CC chemokine production without IL-2 production. J Immunol 2009; 183: 6167\u20136174.","journal-title":"J Immunol"},{"key":"BFbmt2010261_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/cyto.a.20643","volume":"73","author":"V Appay","year":"2008","unstructured":"Appay V, van Lier RAW, Sallusto F, Roederer M . Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008; 73: 975\u2013983.","journal-title":"Cytometry A"},{"key":"BFbmt2010261_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<455::AID-JMV14>3.0.CO;2-Q","volume":"60","author":"N Tanaka","year":"2000","unstructured":"Tanaka N, Kimura H, Iida K, Saito Y, Tsuge I, Yoshimi A et al. Quantitative analysis of cytomegalovirus load using a real-time PCR assay. In: J Med Virol 2000; 60: 455\u2013462.","journal-title":"J Med Virol"},{"key":"BFbmt2010261_CR26","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","volume":"107","author":"MR Betts","year":"2006","unstructured":"Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107: 4781\u20134789.","journal-title":"Blood"},{"key":"BFbmt2010261_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.0105-2896.2006.00395.x","volume":"211","author":"A Harari","year":"2006","unstructured":"Harari A, Dutoit V, Cellerai C, Bart P-A, Du Pasquier RA, Pantaleo G . Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev 2006; 211: 236\u2013254.","journal-title":"Immunol Rev"},{"key":"BFbmt2010261_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1086\/318089","volume":"183","author":"AP Limaye","year":"2001","unstructured":"Limaye AP, Huang ML, Leisenring W, Stensland L, Corey L, Boeckh M . Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. J Infect Dis 2001; 183: 377\u2013382.","journal-title":"J Infect Dis"},{"key":"BFbmt2010261_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","volume":"8","author":"RA Seder","year":"2008","unstructured":"Seder RA, Darrah PA, Roederer M . T-cell quality in memory and protection: implications for vaccine design. Nature Reviews Immunology 2008; 8: 247\u2013258.","journal-title":"Nature Reviews Immunology"},{"key":"BFbmt2010261_CR30","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3324\/haematol.11912","volume":"93","author":"D Lilleri","year":"2008","unstructured":"Lilleri D, Fornara C, Chiesa A, Caldera D, Alessandrino EP, Gerna G . Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection. Haematologica 2008; 93: 248\u2013256.","journal-title":"Haematologica"},{"key":"BFbmt2010261_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nri1840","volume":"6","author":"G Pantaleo","year":"2006","unstructured":"Pantaleo G, Harari A . Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nature Reviews Immunology 2006; 6: 417\u2013423.","journal-title":"Nature Reviews Immunology"},{"key":"BFbmt2010261_CR32","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1073\/pnas.0502393102","volume":"102","author":"SC Zimmerli","year":"2005","unstructured":"Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart P-A, Pantaleo G . HIV-1-specific IFN-gamma\/IL-2-secreting CD8T cells support CD4-independent proliferation of HIV-1-specific CD8T cells. Proc Natl Acad Sci USA 2005; 102: 7239\u20137244.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt2010261_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1742-6405-3-18","volume":"3","author":"LE Nomura","year":"2006","unstructured":"Nomura LE, Emu B, Hoh R, Haaland P, Deeks SG, Martin JN et al. IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells. AIDS research and therapy 2006; 3: 18.","journal-title":"AIDS research and therapy"},{"key":"BFbmt2010261_CR34","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R . Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. Journal of Virology 2003; 77: 4911\u20134927.","journal-title":"Journal of Virology"},{"key":"BFbmt2010261_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","volume":"443","author":"CL Day","year":"2006","unstructured":"Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443: 350\u2013354.","journal-title":"Nature"},{"key":"BFbmt2010261_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry EJ, Ha S-J, Kaech SM, Haining WN, Sarkar S, Kalia V et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007; 27: 670\u2013684.","journal-title":"Immunity"},{"key":"BFbmt2010261_CR37","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.4049\/jimmunol.179.3.1979","volume":"179","author":"M D'Souza","year":"2007","unstructured":"D'Souza M, Fontenot AP, Mack DG, Lozupone C, Dillon S, Meditz A et al. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J Immunol 2007; 179: 1979\u20131987.","journal-title":"J Immunol"},{"key":"BFbmt2010261_CR38","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/bmt.2009.179","volume":"45","author":"V Gu\u00e9rin","year":"2009","unstructured":"Gu\u00e9rin V, Dalle J, P\u00e9dron B, Ouach\u00e9e-Chardin M, Yakouben K, Baruchel A et al. Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantation. Bone Marrow Transplant 2009; 45: 442\u2013449.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2010261_CR39","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1084\/jem.20042384","volume":"201","author":"T Bunde","year":"2005","unstructured":"Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8\u2009T cells. J Exp Med 2005; 201: 1031\u20131036.","journal-title":"J Exp Med"},{"key":"BFbmt2010261_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20011662","volume":"195","author":"RB Mailliard","year":"2002","unstructured":"Mailliard RB, Egawa S, Cai Q, Kalinska A, Bykovskaya SN, Lotze MT et al. Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responses. J Exp Med 2002; 195: 473\u2013483.","journal-title":"J Exp Med"},{"key":"BFbmt2010261_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.coi.2008.03.007","volume":"20","author":"PJ van de Berg","year":"2008","unstructured":"van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R . Cytotoxic human CD4(+) T cells. Curr Opin Immunol 2008; 20: 339\u2013343.","journal-title":"Curr Opin Immunol"},{"key":"BFbmt2010261_CR42","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.4049\/jimmunol.173.3.1834","volume":"173","author":"EMM van Leeuwen","year":"2004","unstructured":"van Leeuwen EMM, Remmerswaal EBM, Vossen MTM, Rowshani AT, Wertheim-van Dillen PME, Van Lier RAW et al. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004; 173: 1834\u20131841.","journal-title":"J Immunol"},{"key":"BFbmt2010261_CR43","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1111\/j.1600-6143.2008.02425.x","volume":"8","author":"G Nebbia","year":"2008","unstructured":"Nebbia G, Mattes FM, Smith C, Hainsworth E, Kopycinski J, Burroughs A et al. Polyfunctional Cytomegalovirus-Specific CD4+ and pp65 CD8+ T Cells Protect Against High-Level Replication After Liver Transplantation. American Journal of Transplantation 2008; 8: 2590\u20132599.","journal-title":"American Journal of Transplantation"},{"key":"BFbmt2010261_CR44","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","volume":"13","author":"PA Darrah","year":"2007","unstructured":"Darrah PA, Patel DT, De Luca PM, Lindsay RWB, Davey DF, Flynn BJ et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13: 843\u2013850.","journal-title":"Nat Med"},{"key":"BFbmt2010261_CR45","doi-asserted-by":"publisher","first-page":"8468","DOI":"10.1128\/JVI.00228-07","volume":"81","author":"S Kannanganat","year":"2007","unstructured":"Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR . Multiple-cytokine-producing antiviral CD4T cells are functionally superior to single-cytokine-producing cells. J Virol 2007; 81: 8468\u20138476.","journal-title":"J Virol"},{"key":"BFbmt2010261_CR46","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bmt.1705825","volume":"40","author":"G Avetisyan","year":"2007","unstructured":"Avetisyan G, Aschan J, H\u00e4gglund H, Ringd\u00e9n O, Ljungman P . Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT. Bone Marrow Transplant 2007; 40: 865\u2013869.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2010261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010261","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2010261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T13:35:49Z","timestamp":1648042549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2010261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["BFbmt2010261"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2010.261","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,8]]},"assertion":[{"value":"31 March 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}